StenerkvinnslandBerGenBio

BerGenBio appoints non-executive directors

BerGenBio AS has appointed Hilde Furberg and Dr Stener Kvinnsland (picture) as Non-Executive Directors to its Board of Directors, effective immediately.

Ascenion0106

BTO and Ascenion enter partnership to bring research to new markets in Europe

Bergen Teknologioverføring and Ascenion GmbH have signed a partnership agreement to cooperate in the area of assessing and exploiting research findings. This will help bring BTO in a position to introduce technologies from its portfolio to new markets in Europe.

Business ideas sketch

Research + commercialisation = readjustment

– This is a signal of increased emphasis on commercialisation, says Abelia’s manager Håkon Haugli. Today, the Minister of Education and Research received a report on commercialisation of Norwegian research.

one2touch-collage

one2TOUCH receives international attention

“-It makes sense for users to buy keyboard covers for tablets, but for smartphones? That just seems like unnecessary bulk, right?”, asks OFWeek – a Chinese publication with 2 million subscribers. The answer becomes clear when they discover a Norwegian invention

CancerCell

The Research Council increases focus on cancer research

The Research Council and the Norwegian Cancer Society are teaming up to make the results of medical and biotechnical research available faster for cancer patients. Together they have made NOK 45 million available for innovative solutions in cancer diagnosis and treatment.

More news